Pub. L. 118-83, div. B, tit. II, subtit. A, sec. 202 (as amended)

EXTENSION OF AUTHORITY TO ISSUE PRIORITY REVIEW VOUCHERS TO ENCOURAGE TREATMENTS FOR RARE PEDIATRIC DISEASES.

Year: 2024Length: 46 wordsOfficial source
SEC. 202. EXTENSION OF AUTHORITY TO ISSUE PRIORITY REVIEW VOUCHERS TO ENCOURAGE TREATMENTS FOR RARE PEDIATRIC DISEASES. Section 529(b)(5) of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360ff(b)(5)) is amended by striking “September 30, 2024” each place it appears and inserting “December 20, 2024”.
Pub. L. 118-83, div. B, tit. II, subtit. A, sec. 202 (as amended): EXTENSION OF AUTHORITY TO ISSUE PRIORITY REVIEW VOUCHERS TO ENCOURAGE TREATMENTS FOR RARE PEDIATRIC DISEASES. | Justis AI